Comorbidity profile in dementia with Lewy bodies versus Alzheimer's disease: A linkage study between the Swedish dementia registry and the Swedish National Patient Registry

Alzheimer's Research and Therapy

Volumn 6, Issue 5-8, 2014, Pages

  Fereshtehnejad, Seyed Mohammad ^a   Damangir, Soheil ^a   Cermakova, Pavla ^a,b   Aarsland, Dag ^a,c   Eriksdotter, Maria ^a,d   Religa, Dorota ^a,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^c STAVANGER UNIVERSITY HOSPITAL   (Norway)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CHOLINESTERASE INHIBITOR; HYPNOTIC AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHARLSON COMORBIDITY INDEX; COGNITION; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DIFFUSE LEWY BODY DISEASE; DISEASE REGISTRY; FEMALE; HUMAN; ICD-10; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MINI MENTAL STATE EXAMINATION; RISK ASSESSMENT; SWEDEN;

EID: 84908009297     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/s13195-014-0065-2     Document Type: Article

References (54)

1. Lewy body disease and dementia. A review. S Kalra, C Bergeron, AE Lang, Arch Intern Med 1996 156 487 493 10.1001/archinte.1996.00440050031004 8604954
2. The use and costs of health and social services in patients with longstanding substance abuse. C Vossius, I Testad, R Skjaeveland, S Nesvag, BMC Health Serv Res 2013 13 185 10.1186/1472-6963-13-185 23692822
3. Long-term mortality in a cohort of home-dwelling elderly with mild Alzheimer's disease and Lewy body dementia. R Oesterhus, H Soennesyn, A Rongve, C Ballard, D Aarsland, C Vossius, Dement Geriatr Cogn Disord 2014 38 161 169 10.1159/000358051 24732348
4. Time until nursing home admission in people with mild dementia: comparison of dementia with Lewy bodies and Alzheimer's dementia. A Rongve, C Vossius, S Nore, I Testad, D Aarsland, Int J Geriatr Psychiatry 2014 29 392 398 10.1002/gps.4015 23943275
5. Differences in rate of functional decline across three dementia types. DP Gill, RA Hubbard, TD Koepsell, MJ Borrie, RJ Petrella, DS Knopman, WA Kukull, Alzheimers Dement 2013 9 63 S71 10.1016/j.jalz.2012.10.010 23643459
6. Measuring case-mix and outcome for older people in acute hospital care across Europe: the development and potential of the ACMEplus instrument. M Espallargues, I Philp, DG Seymour, SE Campbell, W Primrose, S Arino, E Dunstan, G Lamura, P Lawson, E Mestheneos, B Politynska, I Raiha, QJM 2008 101 99 109 10.1093/qjmed/hcm136 18194975
7. Mortality risk after dementia diagnosis by dementia type and underlying factors: a cohort of 15,209 patients based on the Swedish dementia registry. S Garcia-Ptacek, B Farahmand, I Kareholt, D Religa, ML Cuadrado, M Eriksdotter, J Alzheimers Dis 2014 41 467 477 24625796
8. Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease. C Ballard, C Holmes, I McKeith, D Neill, J O'Brien, N Cairns, P Lantos, E Perry, P Ince, R Perry, Am J Psychiatry 1999 156 1039 1045 10401449
9. Risk factors for dementia with Lewy bodies: a case-control study. BP Boot, CF Orr, JE Ahlskog, TJ Ferman, R Roberts, VS Pankratz, DW Dickson, J Parisi, JA Aakre, YE Geda, DS Knopman, RC Petersen, BF Boeve, Neurology 2013 81 833 840 10.1212/WNL.0b013e3182a2cbd1 23892702
10. Key neuropsychiatric symptoms in common dementias: prevalence and implications for caregivers, clinicians, and health systems. TI Sadak, J Katon, C Beck, BB Cochrane, S Borson, Res Gerontol Nurs 2014 7 44 52 10.3928/19404921-20130918-01 24079749
11. Depressive symptoms in Alzheimer's disease and lewy body dementia: a one-year follow-up study. F Fritze, U Ehrt, T Hortobagyi, C Ballard, D Aarsland, Dement Geriatr Cogn Disord 2011 32 143 149 10.1159/000332016 21986003
12. www.svedem.se Swedish Dementia Registry []
13. Dementia diagnosis differs in men and women and depends on age and dementia severity: data from SveDem, the Swedish Dementia Quality Registry. D Religa, K Spangberg, A Wimo, AK Edlund, B Winblad, M Eriksdotter-Jonhagen, Dement Geriatr Cogn Disord 2012 33 90 95 10.1159/000337038 22433665
14. Net costs of dementia in Sweden-an incidence based 10 year simulation study. A Skoldunger, A Wimo, K Johnell, Int J Geriatr Psychiatry 2012 27 1112 1117 10.1002/gps.2828 22298311
15. The ICD-10 Classification of Mental and Behavioral Disorders: Diagnostic Criteria for Research World Health Organization, Geneva 1993
16. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. IG McKeith, DW Dickson, J Lowe, M Emre, JT O'Brien, H Feldman, J Cummings, JE Duda, C Lippa, EK Perry, D Aarsland, H Arai, CG Ballard, B Boeve, DJ Burn, D Costa, T Del Ser, B Dubois, D Galasko, S Gauthier, CG Goetz, E Gomez-Tortosa, G Halliday, LA Hansen, J Hardy, T Iwatsubo, RN Kalaria, D Kaufer, RA Kenny, A Korczyn, Neurology 2005 65 1863 1872 10.1212/01.wnl.0000187889.17253.b1 16237129
17. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. MF Folstein, SE Folstein, PR McHugh, J Psychiatr Res 1975 12 189 198 10.1016/0022-3956(75)90026-6 1202204
18. Reliability of acute pancreatitis diagnosis coding in a National Patient Register: a validation study in Sweden. D Razavi, R Ljung, Y Lu, A Andren-Sandberg, M Lindblad, Pancreatology 2011 11 525 532 10.1159/000331773 22094886
19. Identifying co-morbidity in surgical patients using administrative data with the Royal College of Surgeons Charlson Score. JN Armitage, JH van der Meulen, Br J Surg 2010 97 772 781 10.1002/bjs.6930 20306528
20. The influence of comorbidity scores on re-operations following primary total hip replacement: comparison and validation of three comorbidity measures. M Gordon, A Stark, OG Skoldenberg, J Karrholm, G Garellick, Bone Joint J 2013 95-B 1184 1191 10.1302/0301-620X.95B9.31006 23997129
21. Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem). SM Fereshtehnejad, D Religa, E Westman, D Aarsland, J Lokk, M Eriksdotter, Neuropsychiatr Dis Treat 2013 9 927 935 10.2147/NDT.S45840 23847419
22. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. I McKeith, T Del Ser, P Spano, M Emre, K Wesnes, R Anand, A Cicin-Sain, R Ferrara, R Spiegel, Lancet 2000 356 2031 2036 10.1016/S0140-6736(00)03399-7 11145488
23. Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis. HF Wang, JT Yu, SW Tang, T Jiang, CC Tan, XF Meng, C Wang, MS Tan, L Tan, J Neurol Neurosurg Psychiatry 2014 [Epub ahead of print]
24. Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial. D Aarsland, C Ballard, Z Walker, F Bostrom, G Alves, K Kossakowski, I Leroi, F Pozo-Rodriguez, L Minthon, E Londos, Lancet Neurol 2009 8 613 618 10.1016/S1474-4422(09)70146-2 19520613
25. Prevalence of depression among older adults with dementia living in low- and middle-income countries: a cross-sectional study. P Andreasen, E Lonnroos, MC von Euler-Chelpin, Eur J Pub Health 2014 24 40 44 10.1093/eurpub/ckt014
26. Neuropathology of prodromal Lewy body disease. A Iranzo, E Gelpi, E Tolosa, JL Molinuevo, M Serradell, C Gaig, J Santamaria, Mov Disord 2014 29 410 415 10.1002/mds.25825 24488760
27. Migraine and risk of dementia: a nationwide retrospective cohort study. CS Chuang, CL Lin, MC Lin, FC Sung, CH Kao, Neuroepidemiology 2013 41 139 145 10.1159/000353559 23921376
28. Migraine, depression, and brain volume: the AGES-Reykjavik Study. LS Gudmundsson, AI Scher, S Sigurdsson, MI Geerlings, JS Vidal, G Eiriksdottir, MI Garcia, TB Harris, O Kjartansson, T Aspelund, MA van Buchem, V Gudnason, LJ Launer, Neurology 2013 80 2138 2144 10.1212/WNL.0b013e318295d69e 23700334
29. Headache as a risk factor for dementia: a prospective population-based study. K Hagen, E Stordal, M Linde, TJ Steiner, JA Zwart, LJ Stovner, Cephalalgia 2014 34 327 335 10.1177/0333102413513181 24265286
30. Complex visual hallucinations. Clinical and neurobiological insights. M Manford, F Andermann, Brain 1998 121 1819 1840 10.1093/brain/121.10.1819 9798740
31. Olfaction and neurological diseases: a review of the literature. G Demarquay, P Ryvlin, JP Royet, Rev Neurol 2007 163 155 167 10.1016/S0035-3787(07)90387-2 17351535
32. Alzheimer disease and stroke: cognitive and neuroimaging predictors of AD and stroke. C Ballard, MJ O'Sullivan, Nat Rev Neurol 2013 9 605 606 10.1038/nrneurol.2013.215 24145371
33. Prevalence of vascular lesions in dementia with Lewy bodies. A postmortem study. KA Jellinger, J Neural Transm 2003 110 771 778 10.1007/s00702-003-0822-z 12811637
34. Vascular complications in dementia with Lewy bodies: a postmortem study. D Isojima, T Togo, K Kosaka, H Fujishiro, H Akatsu, O Katsuse, S Iritani, T Matsumoto, Y Hirayasu, Neuropathology 2006 26 293 297 10.1111/j.1440-1789.2006.00699.x 16961064
35. Complications of severe cerebral amyloid angiopathy in the course of dementia with Lewy bodies. A case report. T Mendel, E Bertrand, GM Szpak, T Stepien, T Wierzba-Bobrowicz, Folia Neuropathol 2010 48 293 299 21225512
36. Amyloid angiopathy in diffuse Lewy body disease. E Wu, RB Lipton, DW Dickson, Neurology 1992 42 2131 2135 10.1212/WNL.42.11.2131 1436523
37. Concomitant pathologies among a spectrum of parkinsonian disorders. BN Dugger, CH Adler, HA Shill, J Caviness, S Jacobson, E Driver-Dunckley, TG Beach, Parkinsonism Relat Disord 2014 20 525 529 10.1016/j.parkreldis.2014.02.012 24637124
38. Atypical antipsychotics and risk of cerebrovascular accidents. N Herrmann, M Mamdani, KL Lanctot, Am J Psychiatry 2004 161 1113 1115 10.1176/appi.ajp.161.6.1113 15169702
39. Hypnotics and mortality in an elderly general population: a 12-year prospective study. I Jaussent, ML Ancelin, C Berr, K Peres, J Scali, A Besset, K Ritchie, Y Dauvilliers, BMC Med 2013 11 212 10.1186/1741-7015-11-212 24070457
40. Short- and long-term mortality risk associated with the use of antipsychotics among 26,940 dementia outpatients: a population-based study. EM Langballe, B Engdahl, H Nordeng, C Ballard, D Aarsland, G Selbaek, Am J Geriatr Psychiatry 2014 22 321 331 10.1016/j.jagp.2013.06.007 24016844
41. Antipsychotic therapy and short-term serious events in older adults with dementia. PA Rochon, SL Normand, T Gomes, SS Gill, GM Anderson, M Melo, K Sykora, L Lipscombe, CM Bell, JH Gurwitz, Arch Intern Med 2008 168 1090 1096 10.1001/archinte.168.10.1090 18504337
42. Exposure to antipsychotics and risk of stroke: self controlled case series study. IJ Douglas, L Smeeth, BMJ 2008 337 1227 10.1136/bmj.a1227 18755769
43. Differences in drug therapy between dementia disorders in the Swedish dementia registry: a nationwide study of over 7,000 patients. K Johnell, D Religa, M Eriksdotter, Dement Geriatr Cogn Disord 2013 35 239 248 10.1159/000348408 23485654
44. Anti-dementia drugs and co-medication among patients with Alzheimer's disease: investigating real-world drug use in clinical practice using the Swedish Dementia Quality Registry (SveDem). SM Fereshtehnejad, K Johnell, M Eriksdotter, Drugs Aging 2014 31 215 224 10.1007/s40266-014-0154-8 24497071
45. Psychotropic drug use among people with dementia-a six-month follow-up study. M Gustafsson, S Karlsson, Y Gustafson, H Lovheim, BMC Pharmacol Toxicol 2013 14 56 10.1186/2050-6511-14-56 24196341
46. Comparison of prescription drug use between community-dwelling and institutionalized elderly in Sweden. K Johnell, J Fastbom, Drugs Aging 2012 29 751 758 10.1007/s40266-012-0002-7 23018611
47. Cardiovascular medication burden in dementia disorders: a nationwide study of 19,743 dementia patients in the Swedish Dementia Registry. P Cermakova, SM Fereshtehnejad, K Johnell, B Winblad, M Eriksdotter, D Religa, Alzheimers Res Ther 2014 6 34 10.1186/alzrt264 25024749
48. Heart failure and Alzheimer's disease. P Cermakova, M Eriksdotter, LH Lund, B Winblad, P Religa, D Religa, J Intern Med 2014 [Epub ahead of print]
49. Comorbidity in dementia: update of an ongoing autopsy study. S Magaki, WH Yong, N Khanlou, S Tung, HV Vinters, J Am Geriatr Soc 2014 62 9 1722 1728 10.1111/jgs.12977 25039832
50. Epidemiology, co-morbidities, and medication use of patients with Alzheimer's disease or vascular dementia in the UK. P Imfeld, YB Brauchli Pernus, SS Jick, CR Meier, J Alzheimers Dis 2013 35 565 573 23455986
51. Alzheimer's disease and related dementias increase costs of comorbidities in managed Medicare. JW Hill, R Futterman, S Duttagupta, V Mastey, JR Lloyd, H Fillit, Neurology 2002 58 62 70 10.1212/WNL.58.1.62 11781407
52. Alzheimer's disease or other dementia and medical care utilization. ED Eaker, SF Mickel, PH Chyou, NJ Mueller-Rizner, JP Slusser, Ann Epidemiol 2002 12 39 45 10.1016/S1047-2797(01)00244-7 11750239
53. External review and validation of the Swedish national inpatient register. JF Ludvigsson, E Andersson, A Ekbom, M Feychting, JL Kim, C Reuterwall, M Heurgren, PO Olausson, BMC Public Health 2011 11 450 10.1186/1471-2458-11-450 21658213
54. http://www.ucr.uu.se/svedem/index.php/om-svedem/arsrapporter Arsrapport SveDem 2012 []